Egon Dzintars
Family Medicine · Rapid City, SDNPI 1770530438
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 268 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,378 and has fallen 68.3% since, to $437 in 2022. Among family medicine clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 268 payments — averaging $13.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$565
- Boehringer Ingelheim$423
- Lilly USA, LLC$399
- Pfizer$397
- Takeda Pharmaceuticals U.S.A., Inc.$287
- AstraZeneca$282
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,674100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 41 | $565 |
| Boehringer Ingelheim | 23 | $423 |
| Lilly USA, LLC | 32 | $399 |
| Pfizer | 33 | $397 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $287 |
| AstraZeneca | 10 | $282 |
| Merck | 25 | $253 |
| Novo Nordisk | 26 | $242 |
| GSK | 16 | $156 |
| Amarin Pharma, Inc. | 7 | $123 |
| Johnson & Johnson | 7 | $117 |
| AbbVie(2 entities) | 5 | $74 |
| Eisai Inc. | 4 | $61 |
| Teva Pharmaceuticals USA, Inc. | 4 | $49 |
| Bayer | 3 | $49 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Astellas Pharma US Inc | 2 | $34 |
| Abbott | 1 | $23 |
| Grifols USA, LLC | 2 | $22 |
| Biogen | 1 | $16 |
| Novartis | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$136
- SYMBICORT$136
- BEVESPI AEROSPHERE$136
- JARDIANCE$125
How this compares
$3,674 in reported general payments places this provider in the 95th percentile of 408 family medicine providers in South Dakota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Furosemide | 29 | $457 |
| Losartan Potassium | 52 | $239 |
| Metoprolol Succinate | 52 | $233 |
| Levothyroxine Sodium | 26 | $231 |
| Simvastatin | 52 | $218 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 12 | $82 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Rapid City
- Kyla Helm-SwansonRapid City$22K
- Kinsey Shultz PiatzRapid City$5K
- Kay KeltsRapid City$5K
- Erika ToyodaRapid City$2K
- Carol ZielikeRapid City$2K
- Lorelee StockRapid City$2K
- Andrew BurchettSioux Falls$13K
- Lornell HansenSioux Falls$11K
- Michael GerlachMitchell$9K
- Jeffry MeyerSioux Falls$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.